Nuclear Medicine/ Radiopharmaceuticals Market

Market Insights

Nuclear medicine and radiopharmaceuticals are agents used to diagnose certain medical problems or treat certain diseases. Increasing awareness of radiopharmaceuticals, the growing number of pharmaceutical companies, and rising research institutes are major factors assisting the growth of the nuclear medicine and radiopharmaceuticals market globally.

The report titled “Nuclear Medicine and Radiopharmaceuticals Market: Growth, Future Prospects, and Competitive Analysis, 2017–2025” offers strategic insights into the overall radiopharmaceuticals market, along with

market size and estimates for the duration of 2015–2025. The research study covers an in-depth analysis of market segments based on type (diagnostic and therapeutic radiopharmaceuticals), application (diagnostics, diagnostic applications), and different geographical regions.

Geographically, the global nuclear medicine and radiopharmaceuticals market is studied for the following regional markets:

North America

• U.S.
• Canada

Europe

• U.K.
• Germany
• Rest of Europe

Asia-Pacific

• China
• Japan
• Rest of Asia Pacific

Latin America

• Brazil
• Mexico
• Rest of LATAM

Middle East and Africa

• GCC
• the remainder of MEA

The market size and forecast for these regional and country-level markets are presented in this study for the period 2015–2025. Market growth rates for the forecast period 2017–2025 are also included in this report, considering 2016 as the base year.Along with quantitative information, qualitative information sets and assessment tools are provided in this study for a better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges, and opportunities assists the readers in understanding the ongoing trends in the global nuclear medicine and radiopharmaceutical markets.

Tools such as market positioning of key players and appealing investment propositions provide the reader with insights into the global nuclear medicine and radiopharmaceuticals market’s competitive scenario. This report concludes with a company profiles section that highlights major information about the key players engaged in the global nuclear medicine and radiopharmaceuticals market. In-depth competitive environment analysis and historical year (2015) market size data are also provided in the report.Thus, the research study provides a holistic view of the global radiopharmaceuticals market, offering market size and estimates for the period from 2015 to 2025, keeping in mind the above-mentioned factors.

Based on type, the global nuclear medicine and radiopharmaceuticals market is segmented as follows:

• Diagnostics radiopharmaceuticals
• SPECT Radiopharmaceuticals
• Iodine-123
• Technetium-99m
• Xenon-133
• Thallium-201
• Fluorine-18
• Gallium-67
• Other SPECT Isotopes
• PET Radiopharmaceuticals
• Rubidium 82
• Fluorine 18
• Other PET radiopharmaceuticals
• Therapeutic Radiopharmaceutical
• Beta Emitters
• Phosphorus 32
• Iodine 131
• Strontium 89
• Yttrium 90
• Samarium 153
• Rhenium 186/188
• Lutetium-177
• Other beta emitters
• Alpha Emitter
• Radium 223
• Bismuth 213
• Other beta emitters
• Brachytherapy
• Iridium -192
• Palladium-103
• Iodine-125
• Cesium-131

Radiopharmaceuticals are unique medicinal formulations containing radioactive substances or radioactive drugs that are used for diagnosis and therapeutic interventions. It is observed that, in the base year 2016, diagnostic radiopharmaceuticals were the major revenue-generating segment due to the rising incidence of cancer and cardiac disease. Improved affordability, more precise techniques, and advancements in PET and SPECT scanning are prime factors driving the growth of the radiopharmaceutical market. Due to the increased sensitivity, improved image quality, shorter scan times, and potential to do multiple scans, PET radiopharmaceuticals are expected to show significant market growth during the forecast period.

Based on application, the global nuclear medicine and radiopharmaceuticals market is segmented as follows:

Therapeutic

• Thyroid
• Oncology
• Bone Metastasis
• Other Applications

Diagnostics

• Cardiology
• Thyroid
• Oncology
• Other Therapeutic Applications

A radiopharmaceutical is a radioactive pharmaceutical agent that is used for diagnostic or therapeutic procedures, depending on its physicochemical and radiation properties. The application of radiopharmaceuticals is categorized into two major areas: diagnostic and therapeutic. It is estimated that therapeutic applications will show the fastest market growth during the forecast period due to their advantages over traditional drug therapies, such as targeted therapeutic action and fewer side effects. Radiopharmaceuticals’ application in cardiology and oncology is anticipated to grow significantly during the forecast period due to their increasing applicability in the diagnosis of diseases; furthermore, the growing prevalence of different forms of cancer and cardiovascular disease will fuel market growth. However, stringent regulatory guidelines regarding the manufacturing of radiopharmaceuticals may negatively impact the market growth of these drugs.

For the purpose of this study, the nuclear medicine and radiopharmaceuticals market is categorized into:

• North America
• Europe
• Asia Pacific
• Latin America (LATAM)
• Middle East and Africa (MEA)

It is observed that in the base year 2016, North America was the largest revenue contributor in the global nuclear medicine and radiopharmaceuticals market; the market’s growth is mainly driven by the United States. Technological advancement, higher investment in R&D activities, the presence of key manufacturers, and the presence of a large number of research institutes are major factors that are driving the radiopharmaceuticals market in North America. However, Asia Pacific is expected to show lucrative growth during the forecast period due to the increasing partnership of key players with local manufacturers, the growing incidence and mortality of severe diseases, the growing number of geriatric populations, and the rapidly expanding pharmaceutical industries in this region. Emerging Asian countries such as China and India are expected to exhibit the highest market growth due to their developing economic conditions and the growing partnership of key players with local manufacturers.

Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Assumptions

Chapter 2 Executive Summary
2.1 Global Nuclear Medicine/ Radiopharmaceuticals Market Snapshot
2.2 Global Nuclear Medicine/ Radiopharmaceuticals Market, by Type
2.3 Global Nuclear Medicine/ Radiopharmaceuticals Market, by Application, 2016 (US$ Bn)
2.4 Global Nuclear Medicine/ Radiopharmaceuticals Market Share, by Geography, 2016 (Value %)

Chapter 3 Nuclear Medicine/ Radiopharmaceuticals Market Analysis
3.1 Global Nuclear Medicine/ Radiopharmaceuticals Market Overview
3.2 Market Dynamics
3.2.1 Market Drivers
3.2.2 Challenges
3.2.3 Opportunities
3.3 Attractive Investment Proposition
3.4 Competitive Landscape of Key Players in Nuclear Medicine/ Radiopharmaceuticals Market
3.5 Top 3 Countries

Chapter 4 Global Nuclear Medicine/ Radiopharmaceuticals Market, by Type
4.1 Overview
4.2 Attractive Investment Proposition: Global Nuclear Medicine/ Radiopharmaceuticals Market, by Type
4.3 Diagnostics radiopharmaceuticals
4.3.1 SPECT Radiopharmaceuticals
4.3.1.1 Iodine-123
4.3.1.2 Technetium-99m
4.3.1.3 Xenon-133
4.3.1.4 Thallium-201
4.3.1.5 Fluorine-18
4.3.1.6 Gallium-67
4.3.1.7 Other SPECT Isotopes
4.3.2 PET Radiopharmaceuticals
4.3.2.1 Rubidium 82
4.3.2.2 Fluorine 18
4.3.2.3 Other PET Radiopharmaceutical
4.4 Therapeutic radiopharmaceuticals
4.4.1 Beta Emitters
4.4.1.1 Phosphorus 32
4.4.1.2 Iodine 131
4.4.1.3 Strontium 89
4.4.1.4 Yttrium 90
4.4.1.5 Samarium 153
4.4.1.6 Rhenium 186/188
4.4.1.7 Lutetium-177
4.4.1.8 Other Beta Emitters
4.4.2 Alfa Emitter
4.4.2.1 Radium 223
4.4.2.2 Bismuth 213
4.4.2.3 Other Beta Emitter
4.4.3 Brachytherapy
4.4.3.1 Iridium -192
4.4.3.2 Palladium-103
4.4.3.3 Iodine-125
4.4.3.4 Cesium-131

Chapter 5 Global Nuclear Medicine/ Radiopharmaceuticals Market, by Application
5.1 Overview
5.2 Attractive Investment Proposition: Global Nuclear Medicine/ Radiopharmaceuticals Market, by Application
5.3 Therapeutic
5.3.1 Thyroid
5.3.2 Oncology
5.3.3 Bone Metastasis
5.3.4 Other Therapeutic Application
5.4 Diagnostic Application
5.4.1 Cardiology
5.4.2 Thyroid
5.4.3 Oncology
5.4.4 Other Therapeutic Application

Chapter 6 Global Nuclear Medicine/ Radiopharmaceuticals Market, By Geography
6.1 Preface
6.2 North America (U.S. & Canada)
6.2.1 North America Nuclear Medicine/ Radiopharmaceuticals Market, by Type, 2015- 2025 (US$)
6.2.2 North America Nuclear Medicine/ Radiopharmaceuticals Market, by Country, 2015- 2025 (US$)
6.3 Europe (U.K., Germany & Rest of Europe)
6.3.1 Europe Nuclear Medicine/ Radiopharmaceuticals Market, by Type, 2015- 2025 (US$)
6.3.2 Europe Nuclear Medicine/ Radiopharmaceuticals Market, by Application, 2015- 2025 (US$)
6.3.3 Europe Nuclear Medicine/ Radiopharmaceuticals Market, by Country, 2015- 2025 (US$)
6.4 Asia Pacific (China, Japan and Rest of APAC)
6.4.1 Asia Pacific Nuclear Medicine/ Radiopharmaceuticals Market, by Type, 2015- 2025 (US$)
6.4.2 Asia Pacific Nuclear Medicine/ Radiopharmaceuticals Market, by Application, 2015- 2025 (US$)
6.4.1 Asia Pacific Nuclear Medicine/ Radiopharmaceuticals Market, by Country, 2015- 2025 (US$)
6.5 Latin America (Brazil, Mexico and Rest of LATAM)
6.5.1 Latin America Nuclear Medicine/ Radiopharmaceuticals Market, by Type, 2015- 2025 (US$)
6.5.2 Latin America Nuclear Medicine/ Radiopharmaceuticals Market, by Application, 2015- 2025 (US$)
6.5.3 Latin America Nuclear Medicine/ Radiopharmaceuticals Market, by Country, 2015- 2025 (US$)
6.6 Middle East and Africa (GCC and Rest of MEA)
6.6.1 Middle East and Africa Nuclear Medicine/ Radiopharmaceuticals Market, by Type, 2015- 2025 (US$)
6.6.2 Middle East and Africa Nuclear Medicine/ Radiopharmaceuticals Market, by Application, 2015- 2025 (US$)
6.6.3 Middle East and Africa Nuclear Medicine/ Radiopharmaceuticals Market, by Country, 2015- 2025 (US$)

Chapter 7 Company Profiles
7.1 Advanced Accelerator Applications S.A.
7.2 Bayer AG
7.3 Bracco Imaging S.p.A
7.4 Cardinal Health, Inc.
7.5 GE Healthcare
7.6 IBA Molecular Imaging
7.7 Lantheus Medical Imaging Inc.
7.8 Mallinckrodt plc.
7.9 Medtronic, plc.
7.10 Nordion, Inc.
7.11 NTP Radioisotopes SOC Ltd.
7.12 Segami Corporation

List of Figures

FIG. 1 Nuclear Medicine/ Radiopharmaceuticals Market: Research Methodology
FIG. 2 Global Nuclear Medicine/ Radiopharmaceuticals Market, by Type, 2016 (US$ Bn)
FIG. 3 Global Nuclear Medicine/ Radiopharmaceuticals Market, by Application, 2016 (US$ Bn)
FIG. 4 Global Nuclear Medicine/ Radiopharmaceuticals Market Share, by Geography, 2016 (Value %)
FIG. 5 Attractive Investment Proposition: Global Nuclear Medicine/ Radiopharmaceuticals Market, by Geography, 2016
FIG. 6 Attractive Investment Proposition: Global Nuclear Medicine/ Radiopharmaceuticals Market, by Type, 2016
FIG. 7 Global SPECT Radiopharmaceuticals Market, 2015 – 2025 (US$ Bn)
FIG. 8 Global Iodine-123 Market, 2015 – 2025 (US$ Bn)
FIG. 9 Global Technetium-99m Market, 2015 – 2025 (US$ Bn)
FIG. 10 Global Xenon-133 Market, 2015 – 2025 (US$ Bn)
FIG. 11 Global Thallium-201 Market, 2015 – 2025 (US$ Bn)
FIG. 12 Global Fluorine-18 Market, 2015 – 2025 (US$ Bn)
FIG. 13 Global Gallium-67 Market, 2015 – 2025 (US$ Bn)
FIG. 14 Other SPECT Isotopes Market, 2015-2025 (US$ Bn)
FIG. 15 Global Rubidium 82 Market, 2015 – 2025 (US$ Bn)
FIG. 16 Global Fluorine 18 Market, 2015 – 2025 (US$ Bn)
FIG. 17 Global Other PET Radiopharmaceutical Market, 2015 – 2025 (US$ Bn)
FIG. 18 Global Beta Emitters Market, 2015 – 2025 (US$ Bn)
FIG. 19 Global Phosphorus 32 Market, 2015 – 2025 (US$ Bn)
FIG. 20 Global Iodine 131 Market, 2015 – 2025 (US$ Bn)
FIG. 21 Global Strontium 89 Market, 2015 – 2025 (US$ Bn)
FIG. 22 Global Yttrium 90 Market, 2015 – 2025 (US$ Bn)
FIG. 23 Global Samarium 153 Market, 2015 – 2025 (US$ Bn)
FIG. 24 Global Rhenium 186/188 Market, 2015 – 2025 (US$ Bn)
FIG. 25 Lutetium-177 Market, 2015-2025 (US$ Bn)
FIG. 26 Other Beta Emitters Market, 2015-2025 (US$ Bn)
FIG. 27 Global Radium 223 Market, 2015 – 2025 (US$ Bn)
FIG. 28 Global Bismuth 213 Market, 2015 – 2025 (US$ Bn)
FIG. 29 Global Other Beta Emitter Market, 2015 – 2025 (US$ Bn)
FIG. 30 Global Iridium -192 Market, 2015 – 2025 (US$ Bn)
FIG. 31 Global Palladium-103 Market, 2015 – 2025 (US$ Bn)
FIG. 32 Global Iodine-125 Market, 2015 – 2025 (US$ Bn)
FIG. 33 Global Cesium-131 Market, 2015 – 2025 (US$ Bn)
FIG. 34 Attractive Investment Proposition: Global Nuclear Medicine/ Radiopharmaceuticals Market, by Application, 2016
FIG. 35 Global Thyroid Market, 2015 – 2025 (US$ Bn)
FIG. 36 Global Oncology Market, 2015 – 2025 (US$ Bn)
FIG. 37 Global Bone Metastasis Market, 2015 – 2025 (US$ Bn)
FIG. 38 Global Other Therapeutic Application Market, 2015 – 2025 (US$ Bn)
FIG. 39 Global Cardiology Market, 2015 – 2025 (US$ Bn)
FIG. 40 Global Thyroid Market, 2015 – 2025 (US$ Bn)
FIG. 41 Global Oncology Market, 2015 – 2025 (US$ Bn)
FIG. 42 Global Other Therapeutic Application Market, 2015 – 2025 (US$ Bn)

List of Tables

TABLE 1 Market Positioning of Key Players in Global Nuclear Medicine/ Radiopharmaceuticals Market
TABLE 2 Top 3 Countries in Global Nuclear Medicine/ Radiopharmaceuticals Market
TABLE 3 Global Nuclear Medicine/ Radiopharmaceuticals Market, by Type, 2015 – 2025 (US$ Bn)
TABLE 4 Global Diagnostics radiopharmaceuticals Market, 2015 – 2025 (US$ Bn)
TABLE 5 Global PET Radiopharmaceuticals Market, 2015 – 2025 (US$ Bn)
TABLE 6 Global Therapeutic radiopharmaceuticals Market, 2015 – 2025 (US$ Bn)
TABLE 7 Global Alfa Emitter Market, 2015 – 2025 (US$ Bn)
TABLE 8 Global Brachytherapy Market, 2015 – 2025 (US$ Bn)
TABLE 9 Global Nuclear Medicine/ Radiopharmaceuticals Market, by Application, 2015 – 2025 (US$ Bn)
TABLE 10 Global Therapeutic Market, 2015 – 2025 (US$ Bn)
TABLE 11 Global Diagnostic Application Market, 2015 – 2025 (US$ Bn)
TABLE 12 Global Nuclear Medicine/ Radiopharmaceuticals Market, by Geography, 2015 – 2025 (US$ Bn)
TABLE 13 North America Nuclear Medicine/ Radiopharmaceuticals Market, by Type, 2015-2025 (US$ Bn)
TABLE 14 North America Nuclear Medicine/ Radiopharmaceuticals Market, by Country, 2015 – 2025 (US$ Bn)
TABLE 15 Europe Nuclear Medicine/ Radiopharmaceuticals Market, by Type, 2015-2025 (US$ Bn)
TABLE 16 Europe Nuclear Medicine/ Radiopharmaceuticals Market, by Application, 2015-2025 (US$ Bn)
TABLE 17 Europe Nuclear Medicine/ Radiopharmaceuticals Market, by Country, 2015 – 2025 (US$ Bn)
TABLE 18 Asia Pacific Nuclear Medicine/ Radiopharmaceuticals Market, by Type, 2015-2025 (US$ Bn)
TABLE 19 Asia Pacific Nuclear Medicine/ Radiopharmaceuticals Market, by Application, 2015-2025 (US$ Bn)
TABLE 20 Asia Pacific Nuclear Medicine/ Radiopharmaceuticals Market, by Country, 2015 – 2025 (US$ Bn)
TABLE 21 Latin America Nuclear Medicine/ Radiopharmaceuticals Market, by Type, 2015-2025 (US$ Bn)
TABLE 22 Latin America Nuclear Medicine/ Radiopharmaceuticals Market, by Application, 2015-2025 (US$ Bn)
TABLE 23 Latin America Nuclear Medicine/ Radiopharmaceuticals Market, by Country, 2015 – 2025 (US$ Bn)
TABLE 24 Middle East and Africa Nuclear Medicine/ Radiopharmaceuticals Market, by Type, 2015-2025 (US$ Bn)
TABLE 25 Middle East and Africa Nuclear Medicine/ Radiopharmaceuticals Market, by Application, 2015-2025 (US$ Bn)
TABLE 26 Middle East and Africa Nuclear Medicine/ Radiopharmaceuticals Market, by Country, 2015 – 2025 (US$ Bn)
TABLE 27 Advanced Accelerator Applications S.A.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 28 Bayer AG: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 29 Bracco Imaging S.p.A: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 30 Cardinal Health, Inc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 31 GE Healthcare: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 32 IBA Molecular Imaging: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 33 Lantheus Medical Imaging Inc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 34 Mallinckrodt plc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 35 Medtronic, plc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 36 Nordion, Inc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 37 NTP Radioisotopes SOC Ltd.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 38 Segami Corporation: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)